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Abstract
In the framework of the International Nuclear Workers Study conducted in France, the UK and the 
U.S. (INWORKS), updated and expanded methods were developed to convert recorded doses of 
ionizing radiation to estimates of organ doses or individual personal dose equivalent [Hp(10)] for a 
total number of 308,297 workers, including 40,035 women. This approach accounts for 
differences in dosimeter response to predominant workplace energy and geometry of exposure and 
for the recently published ICRP report on dose coefficients for men and women separately. The 
overall mean annual individual personal dose equivalent, including zero doses, is 1.73 mSv 
[median = 0.42; interquartile range (IQR): 0.07, 1.59]. Associated individual organ doses were 
estimated. INWORKS includes workers who had potential for exposure to neutrons. Therefore, we 
analyzed neutron dosimetry data to identify workers potentially exposed to neutrons. We created a 
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time-varying indicator for each worker, classifying them according to whether they had a positive 
recorded neutron dose and if so, whether their neutron dose ever exceeded 10% of their total 
external penetrating radiation dose. The number of workers flagged as being exposed to neutrons 
was 13% for the full cohort, with 15% of the cohort in France, 12% of the cohort in the UK and 
14% in the U.S. We also used available information on in vivo and bioassay monitoring to identify 
workers with known depositions or suspected internal contaminations. As a result of this work, 
information is now available that will allow various types of sensitivity analyses.
INTRODUCTION
As part of the International Collaborative Study of Cancer among Radiation Workers (1–5), 
methods were developed to derive estimates of organ doses and measures of uncertainty in 
these dose estimates, from historical records of annual external doses for nuclear industry 
workers in 15 countries (6, 7). Development of these methods, based on previously 
published work (8–11), commenced with a systematic review of historical monitoring 
practices and dosimeters used in participating facilities to identify potential biases and 
uncertainties. Based on this a number of representative dosimeters were selected from those 
used historically in facilities in France, the United Kingdom and the United States. 
Controlled experiments were conducted on phantoms to determine their response to different 
geometries and energies of exposure found in the facilities participating in the study. Next, 
panels of experts were convened to characterize typical exposures of workers at nuclear 
facilities in terms of photon energies and geometries (12). A database of correction factors 
was created to convert historical recorded dose values to estimates of organ doses for 
workers in each facility, adjusting for variations in dosimeter response to predominant 
energy and geometry of exposure (conditions of exposure), as well as yielding estimates of 
uncertainty (6, 7). The same methodology was further extended to the U.S. cohort (13).
Building upon prior work, an international consortium of investigators, led by the 
International Agency for Research on Cancer (IARC), has undertaken an updated study of 
cohorts of nuclear workers in France, the UK and U.S., referred to as the International 
Nuclear Workers Study (INWORKS). While including fewer countries than the prior 15-
country study, INWORKS encompasses more than twice the number of cancer deaths due to 
cancer of the parent study, reflecting updated follow-up of these cohorts and expanded 
cohort definitions (14–21).
The current article summarizes the methods implemented in the parent study (7) and applied 
in INWORKS to convert nuclear workers’ recorded doses to estimates of the mean absorbed 
dose to an organ of interest (i.e., DT) or personal dose equivalent in soft tissue at a depth of 
10 mm [i.e., Hp(10)] (22, 23). Correction factors accounting for differences in dosimeter 
response to conditions of exposure have been modified from previous work (7) in 
accordance with recent recommendations from the International Commission on 
Radiological Protection (ICRP). These factors were derived from existing and newly 
gathered information acquired over the expanded period of observation in all three countries. 
Taken together, the information in this article allows for estimation of organ dose estimates, 
or Hp(10) dose, from historical and contemporary radiation dose records from the nuclear 
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industry in each country. This article focuses on external exposure to ionizing radiation from 
photons, while also addressing neutron dosimetry for nuclear workers in France, the UK and 
U.S.
MATERIALS AND METHODS
Collection of External Dosimetry Records
The INWORKS cohort is comprised of 308,297 workers (including 40,035 female workers) 
for whom individual external radiation dose estimates were recorded in participating nuclear 
facilities and calculated for each year of monitoring. Major efforts were made to obtain 
complete information regarding recorded doses for every individual. Details on the 
collection and abstraction of individual dosimetry records are described elsewhere.2 Briefly, 
exposure information was abstracted from facility dosimetry records by researchers in each 
country who were blinded to the workers’ disease and mortality status. These records were 
used in conjunction with other standard dose reconstruction practices (24) to estimate annual 
occupational doses accrued by each participating worker prior to and during the study 
observation period. The INWORKS study was approved by the IARC Ethics Committee.
Recruitment of study participants focused on a select list of nuclear facilities, within each of 
the three countries, where accrued dose primarily originated from external irradiation by 
low-linear energy transfer (low-LET) penetrating radiation, and had been reasonably well-
measured since the beginning of the nuclear industry. Although the majority of occupational 
dose was attributed to exposures at these facilities, workers may have also been exposed 
during employment elsewhere. For this study, researchers made use of an array of exposure 
information (e.g., national dose registries, previous study information) to obtain more 
complete exposure histories for each study subject.
Types of Dosimeters Used, Conditions of Exposure and Dosimeter Response
Information on dosimeter types used to measure photon radiation was updated to include, 
when available, dosimeters used in the facilities participating in the study in recent years of 
follow-up (see Table 1). If no information was provided regarding implementation of new 
dosimeter types, we assumed that the latest type in use in a given facility remained 
unchanged.
Previously collected information about conditions of exposure was reviewed for INWORKS 
to encompass conditions of exposure in recent years. We had no indication of major changes 
in the exposure conditions of the facilities and therefore, our assessment of exposure 
conditions remained unchanged (12). It should be emphasized that our initial assessment 
already accounted for large variations in exposure conditions (7). As concluded previously 
(7, 25), we assume workers in the participating facilities were predominantly exposed to 
photon radiation in the range between 100 and 3,000 keV. The response of dosimeters in this 
energy range and for predominant geometries of exposure was therefore the primary concern 
in our evaluation of the dosimeters used in the participating facilities.
2Richardson DB, Thierry-Chef I, Kesminiene A, Cardis E. Combined analyses of mortality among nuclear workers - procedures 
document. Lyon, France, 2011.
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Revised Bias and Uncertainty Factors (Correction Factors)
Response of dosimeters to energy and geometry of exposure combined with estimates of 
conditions of exposure in the workplace (taking into account calibration practices) were the 
basic data used to derive bias and uncertainty factors, expressed in terms of Hp(10) values, 
for each period of time when a specific dosimeter type was used in a participating facility.
Conversion coefficients between Hp(10) values and organ doses were updated to follow the 
recent ICRP publication 116 (23). These contemporary conversion coefficients were used to 
derive estimates of colon, lung and red bone marrow doses as well as female breast; the 
quantities of interest for the epidemiological analyses conducted in INWORKS.
Bias and uncertainty factors, specific for each facility and calendar period, were applied to 
recorded doses to generate corrected doses, which are on average, unbiased estimates of the 
organ dose of interest. The corrected doses were derived to ensure that time- and facility-
specific corrections of systematic over- and underestimation of doses as well as associated 
uncertainties were performed. The dose-response analyses are therefore based on data 
comparable between countries and facilities.
As in prior work, errors related to laboratory practices (dosimeter processing and readings) 
were considered to have a minor impact on cumulative doses, since these are the sum of 
independent measurements. Administrative practices such as frequency of monitoring, 
criteria to monitor workers and rules to record missing or below-threshold doses were also 
evaluated as having minor impact on recorded doses, since these tend to have been 
remediated through rereading of old dosimeters and post hoc evaluations of doses for the 
facilities and time periods where practices might have led to systematic over- or 
underestimation of the doses (7).
Exposure to Neutrons
INWORKS includes workers who had potential for exposure to neutrons. In most facilities 
and time periods, if neutron doses were estimated for a worker then the neutron component 
of dose was recorded separately from photon dose. However, some facilities did not always 
distinguish between the sources of exposure in the worker's dose of record, and existing 
records were inadequate to determine the neutron contribution to the reported dose (25). In 
such situations we were not able to separate the component of dose due to photon exposure. 
The INWORKS analysis proceeds under the assumption that the vast majority of external 
recorded dose was due to photon radiation. Therefore, the photon component of the organ-
absorbed doses is likely to be slightly overestimated for those individuals with contributions 
from neutrons included in recorded values.
One challenge encountered when estimating neutron doses was a lack of documented 
recording practices, which made it difficult to identify the neutron component of measured 
dose. Another important challenge remains in the design of neutron dosimeters suitable for 
detecting neutrons with energy ranging from about 1 meV to around 20 MeV (26). In the 
early 1950s multi-element film dosimeters were introduced for photon radiation monitoring. 
These film dosimeters typically included Cd, Ag or Rh filters dedicated to the estimation of 
doses from thermal neutrons. However, the technology was inadequate for measuring the 
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full energy range, and neutrons in the range of 0.05 eV to 500 keV could not be measured at 
all. Neutron monitoring evolved over the years with increased capacity to measure neutrons 
from various energy ranges. NTA film dosimeters (nuclear emulsion) were introduced in the 
three participating countries in the 1950s and 1960s and were used for fast neutron 
detection. Albedo dosimeters were developed in parallel, with the main objective of 
measuring neutrons in a much wider energy range including intermediate neutrons (with 
energy between about 0.4 eV and 100 keV). However, albedo dosimeters must be calibrated 
specifically for conditions of each workplace, which should remain stable with time. Also, 
while they do detect neutrons with energies up to 100 keV with little energy dependence in 
terms of fluence, their dose equivalent response above 10 keV is very much lower. Etched 
track dosimeters were introduced in the 1980s and are mainly used to detect fast neutrons, 
although many systems are able to measure thermal neutrons as well. However, they are less 
likely to measure intermediate energy neutrons with acceptable efficiency, and they have 
poor angle dependence of response.
Only sparse information on the period of use of specific neutron dosimeter types in each 
participating facility was available from the questionnaires of the parent study, and it was not 
feasible to conduct detailed surveys on dosimeter types and conditions of exposure (i.e., 
energy and geometry of neutron fields in specific workplaces). Unrecorded neutron doses 
may arise from exposures outside the detection range of the dosimeter (e.g., neutrons of 
energies below the threshold for NTA film) or when the exposed worker was not monitored. 
Widespread personal neutron monitoring was rare in earlier years because dosimetry 
processing was difficult and expensive. Typically, groups of workers considered to have a 
low potential for substantial neutron exposures were not issued neutron dosimeters. In those 
cases, radiation exposure was controlled by limiting the duration of exposure and doses were 
not recorded. In addition, in some facilities where a potential for neutron exposures existed, 
only a fraction of the issued dosimetry was processed in each monitoring cycle.3
An additional issue for the recording of neutron doses arises from the reporting level 
employed by dosimetry services. In this study, the average annual Hp(10) was only 1.73 
mSv, so most positive photon dosimeter readings would have been only just above the 
reporting level. The neutron dose could be a significant fraction of the photon dose but still 
below the reporting threshold.
To evaluate possible unrecorded neutron doses, the distribution of neutron dose by time 
periods and facility was analyzed, together with the available information on neutron 
dosimetry technology in participating facilities. In principle, it should be possible to detect 
underestimation of neutron doses if, at the time when a new dosimeter was introduced, both 
the number of workers with positive neutron doses increased and neutron doses themselves 
increased (i.e., mean neutron dose increased). Distributions of neutron doses were therefore 
drawn for the facilities with a large number of workers monitored for neutrons (at least 
1,000 workers in a given year). For each facility and each year of monitoring, we assessed: 
1. the number of workers monitored for X rays and gamma rays; 2. the number of workers 
3Personal communication. Summary of discussions between Drs. François Trompier (France, IRSN), Guenther Dietze (Germany), 
David Bartlett (UK), Timothy Taulbee (U.S., NIOSH) and Rick Tanner (UK, HPA). Meeting held in Lyon, France, February 2013.
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monitored for neutrons; 3. the mean individual neutron dose (zero doses included); 4. the 
mean individual neutron dose (positive values only); and 5. the number of workers with 
positive values.
In addition, for analyses in INWORKS we used the available records of estimated neutron 
doses to construct categories of neutron exposure potential for the purposes of addressing 
concerns about confounding of associations between estimated external dose from photon 
exposure and mortality by neutron exposure.
RESULTS
Response of Dosimeters to Conditions of Exposure to Photon Radiation
Since the early 1990s [the period covered by a prior report (7)], thermoluminescent 
dosimeters have been widely used in France, the UK and the U.S. (Fig. 1), with reduced use 
of multi-element film dosimeters. Table 1 provides the characteristics of the dosimeters used 
in a selection of facilities [one nuclear power plant (NPP) and one “mixed activities” facility 
per country]. Updated estimated bias and uncertainty factors for Hp(10) and several organ-
specific doses are also provided for these in Table 1. A table is available from the authors 
upon request that provides information about the types of historical practices used over the 
range of employment settings, facilities and countries included in INWORKS. As mentioned 
previously, if no information was provided to us regarding implementation of new dosimeter 
types, we assumed that the latest type in use in a given facility remained unchanged.
Descriptive Analyses of Dose Estimates in Hp(10)
Doses were recorded in various dosimetric quantities, evolving with time periods and 
countries. The study of errors in dosimetry was conducted to ensure that photon doses, used 
for risk analyses, were comparable. Distributions of doses converted into Hp(10) were 
analyzed to identify major trends in the evolution of doses. Figure 1 provides the 50th, 75th 
and 95th percentile of individual annual Hp(10) values in mSv by country, as well as the 
number of workers employed in each country and each year, together with the main 
dosimeter types by period of use. While improvement in dosimetry technology cannot be 
considered as the only factor affecting dose distribution, since activities as well as radiation 
monitoring practices may have also changed, it can reflect evolution of the dosimetry 
practices in general.
Figure 1 shows that the workforce increased in the 1950s and 1960s in the UK and the U.S., 
reflecting increased nuclear activities for both military applications and development of 
nuclear electricity production. This workforce increase is associated with increasing 
individual annual doses. In France, the increase in the workforce is seen in the late 1960s 
until the early 1970s, the period when a general trend is the decrease of individual annual 
doses in the 1960s and 1970s. This decrease might be related to improved technologies, 
introduction of international rules and radiation protection regulations or decrease in 
production for some activities. Around the same time period, multi-element dosimeters were 
largely introduced together with international dosimetry inter-comparison studies.
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A summary of individual annual doses and individual cumulative doses are provided in 
terms of Hp(10), colon, lung, red bone marrow (RBM) and breast in Tables 2 and 3, 
respectively. Individual annual personal dose equivalent is, on average, 1.73 mSv [median = 
0.42; interquartile range (IQR): 0.07, 1.59]. The mean individual annual personal dose 
equivalent varies from 0.93 in France to 2.26 in the UK, with a much larger dispersion in the 
latter country. The individual mean cumulative personal dose equivalent is 25.2 mSv 
(median = 3.4; IQR: 0.4, 18.4), being again higher in the UK and lower in France. In terms 
of organ doses, individual annual doses are on average lower (due to the depth of the organs 
considered), of the order of 1 mGy, except individual breast doses, in women, which are 
below 0.5 mGy. The mean annual personal dose equivalent for women of 0.53 mSv (median 
= 0.13; IQR: 0, 0.48) was much lower than the mean annual personal dose equivalent for 
men of 1.91 mSv (median = 0.50; IQR: 0.09, 1.82).
Exposure to Neutrons
With the introduction of new neutron dosimeters, there was neither a clear increase in mean 
annual doses (Appendix Fig. A1) nor a clear increase in the number of workers with positive 
recorded neutron doses. Changes in neutron dosimetry practices were often made in periods 
when activities also changed. Consequently, it was difficult to separate the impact of an 
increase in the number of workers with positive neutron dose from an increase in the 
workforce. Therefore, it was not feasible to quantify an underestimation of neutron doses in 
earlier historical periods compared to later historical periods.
Consequently, we created a time-varying indicator for each worker, classifying them 
according to whether they had a positive recorded neutron dose (flag 2), and if so, whether 
their neutron dose ever exceeded 10% of their total external penetrating radiation dose (flag 
3). We looked more specifically at the ratio between neutron and photon doses for workers 
with annual photon dose greater than 1 mSv, and both neutron and photon doses recorded. 
The median, 5th and 95th percentiles of the neutron to photon dose ratio are 0.12, 0.007 and 
1.42, respectively, reflecting the fact that, for the majority of workers with a positive 
recorded neutron dose, the magnitude of the annual neutron dose is small relative to the 
magnitude of the annual photon dose.
Table 4 shows the number of workers flagged for neutron exposure (flags 2 and 3) in each 
country. Thirteen percent of the full cohort was flagged for neutron exposure, with 15%, 
12% and 14% flagged for France, the UK and the U.S., respectively.
DISCUSSION
Cohorts of nuclear industry workers have been followed for decades with the main objective 
being to assess for the risk of adverse health effects from protracted exposure to low doses of 
ionizing radiation. Combined analyses of these cohorts offer the potential to improve 
statistical precision of risk estimates. However, valid estimates of disease risk per unit 
exposure rely on valid and consistent dose estimates. Practices to measure and record 
radiation doses have evolved together with technology. Understanding the evolution of these 
practices is important in characterizing the main sources of errors in dose estimates, when 
doses in different countries and different time periods are measured to evaluate radiation 
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risks. The method to quantify bias and uncertainty in photon dose estimates has been 
previously reported (7).
The French, UK and U.S. cohorts were followed until the end of 2004, 2001 and 2005, 
respectively. It should be noted that no major modification on photon dosimetry technology 
was undertaken in recent years in the participating facilities. Thermoluminescent dosimeters 
are now widely used in all three countries. The introduction of electronic dosimetry capable 
of real-time exposure monitoring is a key improvement in dosimetry technology, however, 
electronic dosimeters have yet to see widespread use as a primary dosimeter. This might 
change in the future, in which case quantification of the impact on doses will be required if 
further follow-up of the cohorts is undertaken. While major changes in exposure conditions 
might be due to decommissioning activities, our estimation of the variability in exposure 
conditions is wide enough to account for the introduction of these activities.
The resulting estimates of organ doses are somewhat different than those used in the 15-
country study (7), since conversion coefficients between Hp(10) dose values and specific 
organ doses have been updated using the new ICRP publication (ICRP 116) and coefficients 
were provided for men and women separately (23). Dose to the breast was estimated for 
women since they represent 13% of the INWORKS cohort, i.e., 40,035 workers.
We analyzed available neutron data and assessed the possibility of including reported 
neutron doses in the radiation burden of exposed workers. We also conducted analyses to 
identify periods with unrecorded/underestimated neutron doses due to the weakness of the 
early technology, to detect neutrons in wide energy ranges. From this analysis, it seemed 
unrealistic to correct doses without having clear information on work place allocation and 
work place estimation of conditions of exposure. In addition, the record of neutron 
dosimetry practice, especially indications of radiation weighting factors applied, were 
incomplete for some facilities. We therefore used neutron dosimetry data to construct a time-
varying flag for workers in different categories of neutron exposure. Workers with a positive 
recorded neutron dose were flagged (flag 2) and among them, workers with a neutron dose 
ever exceeding 10% of the total external penetrating radiation dose were identified 
separately (flag 3). We recognize that there are several limitations to this approach. First, this 
approach does not overcome the problem of unrecorded neutron doses that arise either when 
workers were not monitored for neutrons (but were exposed to them) or when neutron doses 
were below the reporting threshold. Second, it does not address the problem of unidentified 
neutron doses that arise when workers were monitored for neutrons but data are only 
available for neutron dose summed with X-ray and gamma-ray doses (with no indication in 
the neutron dose field of the neutron component). In France and the U.S., neutron dose was 
recorded and computerized separately. However, in the UK NRRW records, for some sites/
periods, the recorded external dose reflects measured photon and neutron doses, and we have 
not been able to separate out the photon component. The estimate of external dose was 
assumed to primarily reflect photon doses and the resulting organ absorbed doses are 
potentially overestimated for those individuals also exposed to neutrons.
Addressing these limitations would require an assessment of neutrons independent of 
available computerized neutron dosimetry data (e.g., exposure potential based on work 
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location and activity). However, detailed job history data are not available for all workers 
(e.g., UK NRRW cohort members) and resources are not available for a systematic 
collection and classification of neutron exposure potential across INWORKS. To avoid 
exclusion of workers, sensitivity analyses will be conducted under different scenarios of 
dose distribution to assess the potential bias due to neutron exposure misclassification.
Some workers in the nuclear industry also received radiation dose from internal depositions 
of radionuclides including tritium. In France and the UK recorded doses, when available, 
were used together with information on exposure conditions to identify workers 
contaminated with tritium. In some periods, the tritium contribution to the dose might have 
been included in the recorded whole-body dose. In some U.S. facilities, tritium doses were 
recorded separately and used to identify workers exposed to tritium. Among the cohorts 
included in INWORKS, the vast majority had a relatively small tritium dose contribution, 
although tritium doses were an important part of the total dose at the Savannah River Site in 
the U.S. (27).
In general, reconstructing doses to individual organs from internal contamination requires 
knowledge of the characteristics of the contaminant and understanding of conditions of 
exposure to make use of the results of individual biological samples that are available in the 
dosimetry records of the participating facilities (25). Estimation of doses from intakes of 
radionuclides requires knowledge of the mode of intake, particle size, chemical form and 
solubility. Doses are received over a period that depends on retention of the nuclide in 
specific organs and complex models have been developed for dose estimation based on 
measurements of excretion (28, 29). Efforts are currently underway in participating countries 
to assess organ doses for contaminated workers, individually, but these are currently 
available only for a subset of contaminated workers (30). Therefore, this information could 
not be used in the current study to provide overall organ doses that integrate both internal 
and external exposures. In a future follow-up study of the cohorts, we might be able to do so, 
if organ doses from internal contamination could be evaluated for all contaminated workers. 
Major efforts were made, however, to identify and flag workers with potential for substantial 
doses from intake (>10% of the annual limit of intake). Criteria for flagging the workers 
varied between countries and facilities, they were all based on monitoring and/or workplace 
activities. Major efforts were made in the participating countries to refine flags for workers 
with known depositions or suspected contaminations. In INWORKS, workers who were 
flagged for internal contamination were not excluded from the analyses. In INWORKS, 
workers were grouped into two categories: those with known (or suspected) deposition and 
those with no contamination. The numbers of workers who were flagged for known 
deposition (France, UK and U.S.) and suspected deposition (UK) are provided per country in 
the Appendix. Sensitivity analyses will be conducted, using a variety of realistic scenarios 
that address the distribution of internal exposures in relevant participating facilities.
CONCLUSIONS
Within INWORKS, we conducted an analysis of the dosimetric data to: 1. Estimate organ 
doses for workers exposed to photon radiation with appropriate quantification of errors in 
doses; 2. Analyze neutron dose data to assess the possibility to include the neutron 
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component of exposure in the dose estimation; and 3. Explore possibilities for also 
integrating organ doses from internal contamination.
Analysis of photon radiation was based on the work previously implemented in the 15-
Country Study (7) and was updated to include additional years of monitoring in participating 
facilities and account for newly published ICRP dose coefficients for men and women 
separately. The mean annual individual dose in Hp(10) is 1.73 mSv (median = 0.42; IQR: 
0.07, 1.59). Individual doses were estimated for various organs of interest for cancer and 
noncancer risk evaluations. Neutron dose data, however, could be used only to flag workers 
with potential, mostly inadequately measured exposure to neutrons. Information on workers 
internally contaminated was used for flagging, however, estimation of organ doses due to 
internal contamination, if available, could not be integrated into the overall radiation burden. 
Future sensitivity analyses will be performed to evaluate the potential impact of missing 
doses from neutrons and internal contamination.
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APPENDIX
Exposure to Neutrons and Internal Contamination
Since workers exposed to neutrons are included in the INWORKS cohort, analysis of 
neutron data was performed to assess the feasibility for both quantifying possible 
unrecorded neutron doses and including the neutron component of exposure in the dose 
estimation.
We conducted an analysis of the recorded neutron data to detect possible underestimation of 
neutron doses resulting from the inability of earlier dosimeters to measure neutrons from 
various energy ranges. If, at the time a new dosimeter was introduced, the number of 
workers with positive neutron doses increased and neutron doses themselves increased (i.e., 
mean neutron dose increased), we could assume that before the introduction of the new 
dosimeter type, doses were underestimated. However, in our examination of the available 
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data, there was no clear indication of either a change in the number of workers with positive 
neutron dose or a change in the mean recorded neutron dose subsequent to changes in 
technology (see Fig. A1). This may be because the number of workers with positive neutron 
doses is very low or because there is no clear trend in the dose distribution, other than a 
general decrease over calendar time in positive neutron doses. Figure A1 shows the annual 
mean of the positive individual neutron doses together with the number of workers with 
positive neutron doses for a representative facility from each country. Information, as 
provided in the questionnaires from the parent study, on the dosimetry technology is shown 
in parallel.
For the purposes of assessing potential confounding by neutron exposure of estimated 
associations between recorded photon dose and mortality, we constructed a time-varying 
flag for categories of neutron exposure potential. Similarly, we constructed flags for workers 
with known (France, UK and U.S.) or suspected (UK) internal contamination by 
radionuclides. Table A1 shows a summary of the number of workers flagged for neutron 
exposure combined with the number of workers flagged with internal contamination.
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FIG. A1. 
Distribution of mean individual neutron doses (positive values) and number of workers with 
positive neutron doses in a selected facility in France (panel A), the UK (panel B), and the 
U.S. (panel c).
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APPENDIX TABLE A1
Number of Workers Flagged for Neutronsa and Internal Contaminationb
Total 
number 
of 
workers
No internal 
contamination, 
no neutrons
Neutrons only Internal contamination only Internal 
contamination 
and any 
neutronsCountry Flag 1 Flag 2 Flag 3 Flag 2 Total flagged
France 59,003 48,220 5,793 2,486 2,197 307 10,783
UK 147,866 98,140 5,383 2,933 32,502 8,908 49,726
U.S. 101,428 83,157 6,997 3,663 4,307 3,304 18,271
Total 308,297 229,517 18,173 9,082 39,006 12,519 78,780
aWorkers were grouped into three categories. Flag 1: Workers with no monitoring or zero doses. Flag 2: Workers with 
recorded cumulative neutron doses not exceeding 10% of the total equivalent dose for external radiation. Flag 3: Workers 
with recorded cumulative neutron doses exceeding 10% of the total equivalent dose for external radiation.
bWorkers were grouped into two categories. Flag 1: Workers with no deposition. Flag 2: Workers with known (France, UK 
and U.S.) or suspected (UK) deposition.
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FIG. 1. 
Panel A: Individual annual dose distribution in France, expressed in Hp(10) (mSv), with 
associated workforce and dosimeters used over time. Panel B: Individual annual dose 
distribution in the UK, expressed in Hp(10) (mSv), with associated workforce and 
dosimeters used over time (based on latest information available in 1999). Panel C: 
Individual annual dose distributions in the U.S., expressed in Hp(10) (mSv), with associated 
workforce and dosimeters used over time.
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TABLE 2
Distribution of Individual Annual Doses among Cohort Participantsa
Total number 
of workers
Hp(10) (mSv) Colon (mGy) Lung (mGy) RBM (mGy) Breast (mGy) 
(women only)
Cohort (percentage 
of exposed 
workers)
Mean (median; IQR) Mean (median; IQR) Mean (median; IQR) Mean (median; IQR) Mean (median; IQR)
France 59,003 (72%) 0.93 (0.14; 0.00,0.96) 0.64 (0.10; 0.00,0.66) 0.64 (0.10; 0.00,0.66) 0.59 (0.09; 0.00,0.61) 0.21 (0.00; 0.00,0.08)
UK 147,866 (88%) 2.26 (0.64; 0.17,2.08) 1.56 (0.44; 0.12,1.44) 1.55 (0.44; 0.12,1.43) 1.43 (0.41; 0.11,1.32) 0.75 (0.31; 0.12,0.70)
U.S. 101,428 (83%) 1.42 (0.32; 0.05,1.24) 0.99 (0.22; 0.03,0.86) 0.98 (0.22; 0.03,0.85) 0.9 (0.20; 0.03,0.79) 0.31 (0.06; 0,0.27)
Total 308,297 (83%) 1.73 (0.42; 0.07,1.59) 1.20 (0.29; 0.05,1.10) 1.19 (0.29; 0.05,1.09) 1.09 (0.27; 0.04,1.01) 0.43 (0.10; 0,0.39)
Notes. Values include doses recorded as zero. RBM = red bone marrow. IQR = interquartile range (25th percentile, 75th percentile).
a
The cohort includes 268,262 men and 40,035 women.
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TABLE 3
Distribution of Individual Cumulative Doses among Cohort Participantsa
Total number 
of workers
Hp(10) (mSv) Colon (mGy) Lung (mGy) RBM (mGy) Breast (mGy) 
(women only)
Cohort (percentage 
of exposed 
workers)
Mean (median; IQR) Mean (median; IQR) Mean (median; IQR) Mean (median; IQR) Mean (median; IQR)
France 59,003 (72%) 18.4 (2.1; 0.0,17.0) 12.6 (1.4; 0.0,11.6) 12.6 (1.4; 0.0,11.7) 11.6 (1.3; 0.0,10.7) 2.8 (0; 0.0,0.93)
UK 147,866 (88%) 28.7 (4.2; 0.6,2.4) 19.9 (2.9; 0.4,14.1) 19.8 (2.9; 0.4,14.1) 18.2 (2.6; 0.4,12.9) 5.1 (1.4; 0.4,4.3)
U.S. 101,428 (83%) 24.0 (2.9; 0.3,16.7) 16.7 (2.1; 0.2,11.6) 16.6 (2.0; 0.2,11.5) 15.2 (1.9; 0.2,10.6) 3.7 (0.4; 0.0,2.3)
Total 308,297 (83%) 25.2 (3.4; 0.4,18.4) 17.4 (2.3; 0.3,12.8) 17.4 (2.3; 0.3,12.7) 15.9 (2.1; 0.3,11.7) 4 (0.6; 0.0,2.8)
Notes. Values include doses recorded as zero. RBM = red bone marrow. IQR = interquartile range (25th percentile, 75th percentile).
a
The cohort includes 268,262 men and 40,035 women.
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TABLE 4
Number of Workers Flagged for Neutrons
Country Total number of workers No neutrons Flag 1 Neutrons
Flag 2 Flag 3
France 59,003 50,417 6,018 2,568
UK 147,866 130,642 12,435 4,789
U.S. 101,428 87,464 9,179 4,785
Total 308,297 268,523 27,632 12,142
Notes. Workers were grouped into three categories. Flag 1: Workers with no monitoring or zero doses. Flag 2: Workers with recorded cumulative 
neutron doses not exceeding 10% of the total equivalent dose for external radiation. Flag 3: Workers with recorded cumulative neutron doses 
exceeding 10% of the total equivalent dose for external radiation.
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